Commonly used ryanodine receptor activator, 4-chloro-m-cresol (4CmC), is also an inhibitor of SERCA Ca2+ pumps

Pharmacological Reports

Volumn 61, Issue 5, 2009, Pages 838-842

  Al Mousa, Fawaz ^a   Michelangeli, Francesco ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

4 chloro m cresol; Ca2+ pumps; Ryanodine receptor; SERCA

Indexed keywords

CHLOROCRESOL; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STRAIN COS7; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; IC 50; NONHUMAN;

EID: 70549086938     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70139-2     Document Type: Article

References (22)

1. 2+ pumps in the brain. Mol Chem Neuropathol, 1998, 33, 199-208.
2. Bina S, Cowan G, Karaian J, Muldoon S, Mongan P: Effects of caffeine, halothane and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis. Anesthesiology, 2006, 104, 90-100.
3. 2+ channel in rat cerebellum is inhibited by caffeine. Biochem J, 1992, 282, 309-312.
4. Choisy S, Huchet-Cadiou C, Léoty C: Differential effects of 4-chloro-m-cresol and caffeine on skinned fibres from rat fast and slow skeletal muscles. J. Pharmacol Exp Ther, 2000, 294, 884-893. (Pubitemid 30666837)
5. 4021 of the ryanodine receptor type 1 are required for activation by 4-chloro-m-cresol. J Biol Chem, 2006, 281, 21022-21031.
6. Freymond D, Guignet R, Lhote P, Passaquinn AC, Rüegg UT: Calcium homeostasis and glucose uptake of murine myotubes exposed to insulin, caffeine and 4-chloro-m-cresol. Acta Physiol Scand, 2002, 176, 282-292.
7. George CH, Higgs GV, Lai FA: Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res, 2003, 93, 531-540.
8. Hauser CJ, Kannan KB, Deitch EA, Itagaki K: Non-specific effects of 4-chloro-m-cresol may cause calcium flux and respiratory burst in human neutrophils. Biochem Biophys Res Commun, 2005, 336, 1087-1095.
9. Herrmann-Frank A, Richter M, Lehmann-Horn F: 4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle. Biochem Pharmacol, 1996, 52, 149-155. (Pubitemid 26199118)
10. 2+ content in intact amphibian skeletal muscle fibres with 4-chloro-m-cresol. Cell Calcium, 1999, 25, 227-235. (Pubitemid 129747160)
11. 2+ entry in human embryonic kidney (HEK293) cells. Eur J Pharmacol, 2005, 509, 109-115. (Pubitemid 40279068)
12. Matyash M, Matyash V, Nolte C, Sorrentino V, Kettenman H: Requirement of functional ryanodine receptor type 3 for astrocyte migration. FASEB J, 2002, 16, 84-86.
13. 2+ release from cerebellar microsomes. J Biol Chem, 1996, 271, 31818-31823.
14. 2+-activated ATPase of sarcoplasmic reticulum. Biochem J, 1990, 267, 423-429. (Pubitemid 20136076)
15. 2+)ATPase using bile salt detergents to form membranes of lipid to protein ratios or sealed vesicles. Anal Biochem, 1991, 194, 231-236.
16. 2+ stores. Curr Opin Cell Biol, 2005, 17, 135-140. (Pubitemid 40380936)
17. 2+ homeostasis. Toxicol In-Vitro, 2008, 22, 943-952.
18. 2+ release from sarcoplasmic reticulum by activating the ryanodine receptor. Eur J Pharmacol, 2005, 354, 245-251.
19. 2+ transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation associated with malignant hyperthermia. Biochem J, 1994, 381, 661-665.
20. Treves S, Pouliquin P, Moccagatta L, Zorzato F: Functional properties of EGFP-tagged skeletal muscle calcium-release channel (ryanodine receptor) expressed in COS-7 cells: sensitivity to caffeine and 4-choro-m-cresol. Cell Calcium, 2002, 31, 1-12. (Pubitemid 34189552)
21. 2+-A-TPase isoforms transcripts. Am J Physiol, 1995, 269, C775-C784.
22. 2+ release. Mol Pharmacol, 1993, 44, 1192-1201. (Pubitemid 24008603)